Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : HSB-1216
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : Hillstream BioPharma
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the agreement, OncoBay will provide comprehensive clinical and regulatory support for the clinical development program for Hillstream's lead drug HSB-1216, which targets ferroptosis, an emerging new anti-cancer mechanism, resulting in IMCD of drug ...
Brand Name : HSB-1216
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 13, 2023
Lead Product(s) : HSB-1216
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : Hillstream BioPharma
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?